Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Camila Masias"'
Autor:
Scott C. Woller, Kerstin deWit, Helia Robert‐Ebadi, Camila Masias, Frederikus A. Klok, Paul L. denExter, Pierre‐Emmanuel Morange, David Castelli, John‐Bjarne Hansen
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 6, Pp n/a-n/a (2022)
Abstract Background Thrombosis is reported to occur more often among patients with COVID‐19 than otherwise expected in the setting of viral pneumonia and sepsis. Systemic inflammatory biomarkers may be associated with venous thromboembolism (VTE) r
Externí odkaz:
https://doaj.org/article/57c024beef04433fa2eb6faaf939ac71
Autor:
Spero R. Cataland, Peter J. Kourlas, Shangbin Yang, Susan Geyer, Leslie Witkoff, Haiwa Wu, Camila Masias, James N. George, Haifeng M. Wu
Publikováno v:
Blood Advances, Vol 1, Iss 23, Pp 2075-2082 (2017)
Abstract: Although steroids are routinely used as an adjunct to plasma exchange (PEX) therapy in the treatment of immune-mediated thrombotic thrombocytopenic purpura (iTTP), limited data regarding their efficacy or effect on ADAMTS13 biomarkers are a
Externí odkaz:
https://doaj.org/article/57c9c790de8a4a33af482fe0b5ef21e5
Autor:
Shruti, Chaturvedi, Ana G, Antun, Andrew M, Farland, Ryan, Woods, Ara, Metjian, Yara A, Park, Gustaaf, de Ridder, Briana, Gibson, Raj S, Kasthuri, Darla K, Liles, Frank, Akwaa, Todd, Clover, Lisa, Baumann Kreuziger, J Evan, Sadler, Meera, Sridharan, Ronald S, Go, Keith R, McCrae, Harsh Vardhan, Upreti, Angela, Liu, Ming Y, Lim, Radhika, Gangaraju, X Long, Zheng, Jay S, Raval, Camila, Masias, Spero R, Cataland, Andrew, Johnson, Elizabeth, Davis, Michael D, Evans, Marshall A, Mazepa
Publikováno v:
Blood. 140:1335-1344
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring episodes of thrombotic microangiopathy, causing ischemic organ impairment. Black patients are overrepresented in iTTP cohorts in the United States, but racial di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bc4cc94bbaac641f87df27b51dd51a7
https://doi.org/10.1182/blood.2022016640
https://doi.org/10.1182/blood.2022016640
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism
Autor:
Paul L. den Exter, Scott C. Woller, Helia Robert‐Ebadi, Camila Masias, Pierre‐Emmanuel Morange, David Castelli, John‐Bjarne Hansen, Geert‐Jan Geersing, Deborah M. Siegal, Kerstin de Wit, Frederikus A. Klok
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, 2022, 20 (8), pp.1910-1919. ⟨10.1111/jth.15776⟩
Journal of Thrombosis and Haemostasis, 20(8), 1910-1919. WILEY
Journal of Thrombosis and Haemostasis, 2022, 20 (8), pp.1910-1919. ⟨10.1111/jth.15776⟩
Journal of Thrombosis and Haemostasis, 20(8), 1910-1919. WILEY
International audience; Patients with acute venous thromboembolism (VTE) require anticoagulant therapy to prevent recurrent VTE and death, which exposes them to an inherent increased risk of bleeding. Identification of patients at high risk of bleedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b082ba6e20f50e01effa79c0d623cc4
https://hdl.handle.net/1887/3494552
https://hdl.handle.net/1887/3494552
Publikováno v:
Blood. 134:415-420
Insights into immune-mediated thrombotic thrombocytopenic purpura (iTTP) pathophysiology have led to novel targeted therapies. Immunomodulatory strategies target anti-ADAMTS13 antibodies: rituximab is effective in inducing responses in refractory/rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2633fa1de58e61495378e3f884918100
https://doi.org/10.1182/blood.2019000954
https://doi.org/10.1182/blood.2019000954
Autor:
Chenggong Han, Lauren Jay, Spero R. Cataland, Haiwa Wu, Shangbin Yang, Camila Masias, Shili Lin
Publikováno v:
British Journal of Haematology. 189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d8b93fbae85bf5e89f0c745d5ae4e7
https://doi.org/10.1111/bjh.16415
https://doi.org/10.1111/bjh.16415
Autor:
Spero R. Cataland, Camila Masias
Publikováno v:
Blood. 132:903-910
ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, 13) is a metalloprotease responsible for cleavage of ultra-large von Willebrand factor (VWF) multimers. Severely deficient activity of the protease can trigger an acute e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c604fa95f67c24c09ab070a49d67b3eb
https://doi.org/10.1182/blood-2018-02-791533
https://doi.org/10.1182/blood-2018-02-791533
Autor:
Camila Masias, Meera Sridharan, Marshall A. Mazepa, Michael D. Evans, Aric Parnes, Aaron Boothby, Radhika Gangaraju
Publikováno v:
Blood. 138:2084-2084
Background: Immune Thrombotic thrombocytopenic purpura (iTTP) is a relapsing disorder, resulting from depletion of ADAMTS13. With the goal of preventing clinical relapse there has been considerable interest in ADAMTS13 monitoring and preemptive treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5ea93a484443ff97a2c471f725a0e4b
https://doi.org/10.1182/blood-2021-149984
https://doi.org/10.1182/blood-2021-149984
Autor:
Alcinda Flowers, Spero R. Cataland, Camila Masias, Haiwa Wu, Shangbin Yang, Senthil Sukumar, Krista Carter, Chenggon Han, Shili Lin
Publikováno v:
Blood. 136:8-9
Background: Immune mediated thrombotic thrombocytopenic purpura (iTTP) is defined by thrombocytopenia and microangiopathic hemolytic anemia caused by severely deficient ADAMTS13 activity ( Patients/Methods: This analysis utilized samples from patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97822bff12ebe256f6ea3ef4c4e6d53b
https://doi.org/10.1182/blood-2020-142117
https://doi.org/10.1182/blood-2020-142117
Publikováno v:
American Journal of Hematology. 93:E73-E75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7f677873522f4264fe4627847c8bfe8
https://doi.org/10.1002/ajh.25002
https://doi.org/10.1002/ajh.25002